Healthcare -
Biotechnology - NASDAQ - US
$ 1.81
2.84 %
$ 1.15 B
Market Cap
-6.7
P/E
GERN - DEPRECIATION & AMORTIZATION
Depreciation & Amortization GERN - Geron Corporation
1.03 M
LAST VALUE
14.86%
2 YEAR CAGR
77.28%
5 YEAR CAGR
12.43%
10 YEAR CAGR